Mumbai: Shares of PB Fintech have come under pressure after leading brokerages sharply reduced their target prices following proposed changes by the Insurance Regulatory and Development Authority of India (IRDAI) concerning insurance distribution commissions.
The proposed reforms, which include tighter commission structures and caps, have raised concerns about the economics of insurance distribution platforms, particularly in the non-life insurance segment. HSBC, Bank of America Securities (BofA) and Jefferies have all revised their target prices for PB Fintech, the parent company of Policybazaar, although their assessments of the company’s prospects differ.
The proposals are currently at the consultation stage and may change after feedback from stakeholders. Therefore, the brokerage estimates reflect the potential impact of the proposed framework rather than a final regulatory outcome.
HSBC cuts PB Fintech target by 45%
HSBC has made the sharpest revision among the three brokerages. It reduced its target price for PB Fintech to Rs 1,150 from Rs 2,100, representing a 45% cut.
The brokerage also downgraded its rating on the stock to Hold from Buy. HSBC cited the potential impact of proposed insurance distribution reforms, particularly commission caps, on the economics of the business.
HSBC has also reduced its earnings-per-share estimates for PB Fintech. Its FY28 and FY29 EPS estimates have been cut by 56% and 17%, respectively.
According to HSBC, lower take rates could weigh on earnings, although the impact could be partly offset by assumptions of somewhat higher growth and cost savings. The brokerage also identified greater regulatory clarity as an important factor for its future assessment of the company.
BofA cuts target to Rs 1,410
Bank of America Securities has retained its Neutral rating on PB Fintech but reduced its target price by 28.4%, from Rs 1,970 to Rs 1,410.
BofA said the proposed distribution changes could make the insurance distribution business less attractive for larger agents. It has consequently reduced the valuation multiple assigned to PB Fintech’s core business and described the proposed reforms as directionally negative for the online insurance broking industry.
However, BofA expects the impact on Policybazaar’s life and term insurance operations to remain manageable. The brokerage also sees scope for the platform to gain market share across different insurance categories.
BofA further noted that PB Fintech could potentially explore manufacturing health insurance. It said increased investment by PB Health in the hospital business could also help the company build a stronger competitive position, although such developments could have implications for the valuation multiples assigned to the business.
Jefferies lowers target by nearly 25%
Jefferies has retained its Buy rating on PB Fintech while reducing its target price by 24.9%, from Rs 2,050 to Rs 1,540.
The brokerage expects the proposed regulatory changes to have a greater impact on the company’s non-life insurance business than its life insurance operations.
Jefferies said cost optimisation could become the immediate focus for PB Fintech as the company adjusts to the potential changes in insurance distribution economics.
The brokerage has estimated that a 10% reduction in new-business commission rates could result in a 10–12% decline in earnings. However, it also highlighted that the proposed changes remain part of a consultation process and could be modified following stakeholder feedback.
Why commission changes matter for PB Fintech
Policybazaar operates as an online insurance distribution platform, connecting customers with insurance products across categories. Changes to the commissions earned by distributors can therefore have a direct bearing on the economics of the business.
The latest regulatory proposals have prompted brokerages to reassess assumptions around take rates, earnings and valuation. The potential impact is particularly significant for non-life insurance, where Jefferies expects the effect to be larger than in life insurance.
At the same time, BofA has pointed out that the impact on Policybazaar’s life and term insurance business could remain manageable. It also sees the possibility of the company strengthening its market position across insurance categories.
This divergence highlights the uncertainty surrounding the eventual impact of the reforms. While HSBC has taken a more cautious stance and sharply reduced its earnings estimates, BofA and Jefferies continue to see areas where PB Fintech could adapt its business model.
Regulatory outcome remains important
The proposed IRDAI reforms have not yet become a final regulatory framework. The consultation process allows stakeholders to provide feedback, meaning the final provisions could differ from the proposals currently being assessed by brokerages.
For PB Fintech, the eventual structure of commission caps and distribution rules will be important in determining the effect on insurance distribution revenue and profitability.
The company’s ability to control costs, maintain growth and expand its position across insurance categories could also influence how the market assesses the impact of the regulatory changes.
For now, the sharp revisions in target prices from HSBC, BofA and Jefferies reflect increased uncertainty around PB Fintech’s future earnings under the proposed insurance distribution framework. The brokerage targets are estimates based on their respective assumptions and should not be treated as guaranteed future prices.